Published by Michele Maatouk on 18th August 2026
(Sharecast News) - Deutsche Bank downgraded Oxford Biomedica to 'hold' from 'buy' on Tuesday and slashed the price target to 595p from 800p as it revisited the investment case following the "disappointing" first-half trading update.
URL: http://www.digitallook.com/dl/news/story/36148469/...